There is accumulating evidence that SAA is a reliable biomarker for several autoinflammatory and rheumatic diseases, and that it is involved in the pathophysiology of rheumatoid arthritis (RA), familial Mediterranean fever (FMF), sarcoidosis, and vasculitis. Here, SAA1 is linked to sarcoidosis.